161 related articles for article (PubMed ID: 35468659)
1. Reassessing the optimal volume for malignancy detection in serous fluid cytology.
Coconubo DM; Baskota SU; Li R; Srivastava P; Cuda J; Khader S
Cancer Cytopathol; 2022 Jul; 130(7):551-557. PubMed ID: 35468659
[TBL] [Abstract][Full Text] [Related]
2. Adequacy in pleural effusion: What is the minimum volume required for detection of malignant cells?
Jha S; Sethy M; Sharma G; Adhya AK
Diagn Cytopathol; 2022 Jun; 50(6):284-288. PubMed ID: 35362266
[TBL] [Abstract][Full Text] [Related]
3. Optimal fluid volume for detecting malignancy in serous effusions: a single institution experience.
Beg S; Zanettini C; Queiroz L; Marchionni L; Alperstein SA; Siddiqui MT
J Am Soc Cytopathol; 2023; 12(6):415-422. PubMed ID: 37419704
[TBL] [Abstract][Full Text] [Related]
4. Cytohistological correlation in serous effusions using the newly proposed International System for Reporting Serous Fluid Cytopathology: Experience of an oncological center.
Lobo C; Costa J; Petronilho S; Monteiro P; Leça L; Schmitt F
Diagn Cytopathol; 2021 May; 49(5):596-605. PubMed ID: 32339444
[TBL] [Abstract][Full Text] [Related]
5. Application of the International System for Reporting Serous Fluid Cytopathology (TIS): A retrospective institutional study.
Straccia P; Chiappetta M; Magnini D; Cancellieri A
Cytopathology; 2022 May; 33(3):305-311. PubMed ID: 35213747
[TBL] [Abstract][Full Text] [Related]
6. Application of the International System for Reporting Serous Fluid Cytopathology (ISRSFC) on Reporting Pericardial Effusion Cytology.
Rodriguez EF; Jones R; Gabrielson M; Santos D; Pastorello RG; Maleki Z
Acta Cytol; 2020; 64(5):477-485. PubMed ID: 32422631
[TBL] [Abstract][Full Text] [Related]
7. A minimum fluid volume of 75 mL is needed to ensure adequacy in a pleural effusion: a retrospective analysis of 2540 cases.
Rooper LM; Ali SZ; Olson MT
Cancer Cytopathol; 2014 Sep; 122(9):657-65. PubMed ID: 25060164
[TBL] [Abstract][Full Text] [Related]
8. Small orangiophilic squamous-like cells: an underrecognized and useful morphological feature for the diagnosis of malignant mesothelioma in pleural effusion cytology.
Chen L; Caldero SG; Gmitro S; Smith ML; De Petris G; Zarka MA
Cancer Cytopathol; 2014 Jan; 122(1):70-5. PubMed ID: 23983174
[TBL] [Abstract][Full Text] [Related]
9. A prospective study of the volume of pleural fluid required for accurate diagnosis of malignant pleural effusion.
Abouzgheib W; Bartter T; Dagher H; Pratter M; Klump W
Chest; 2009 Apr; 135(4):999-1001. PubMed ID: 19017891
[TBL] [Abstract][Full Text] [Related]
10. Categorisation of peritoneal serous effusions using the International System for Reporting Serous Fluid Cytopathology-A study on gynaecological samples.
Rakheja G; Singh M; Priyadarshnee B; Marimuthu B; Dhar L; Jain S; Khurana N; Rathore A
Cytopathology; 2023 Mar; 34(2):138-145. PubMed ID: 36530023
[TBL] [Abstract][Full Text] [Related]
11. The international system for reporting serous fluid cytopathology-diagnostic categories and clinical management.
Pinto D; Chandra A; Crothers BA; Kurtycz DFI; Schmitt F
J Am Soc Cytopathol; 2020; 9(6):469-477. PubMed ID: 32620534
[TBL] [Abstract][Full Text] [Related]
12. A comparative analysis of conventional cytopreparatory and liquid based cytological techniques (Sure Path) in evaluation of serous effusion fluids.
Dadhich H; Toi PC; Siddaraju N; Sevvanthi K
Diagn Cytopathol; 2016 Nov; 44(11):874-879. PubMed ID: 27546351
[TBL] [Abstract][Full Text] [Related]
13. Optimal Volume Assessment for Serous Fluid Cytology.
Christofidis K; Theochari M; Mavropoulos Papoudas S; Kiohou L; Sousouris S; Dimitriadou A; Volakakis N; Maounis N; Mikou P
Biomedicines; 2024 Apr; 12(4):. PubMed ID: 38672252
[TBL] [Abstract][Full Text] [Related]
14. A Retrospective Analysis of the Application of the Newly Proposed International System for Reporting Serous Fluid Cytopathology on Serous Effusion Specimens: An Institutional Experience.
Rajeswaran PK; Srinivasan V; Mahesh SSV; Ashok AU
Acta Cytol; 2023; 67(1):70-79. PubMed ID: 36476509
[TBL] [Abstract][Full Text] [Related]
15. Application of international system for reporting serous fluid cytology (ISRSFC) in effusion samples-a prospective study in an oncology setting.
Sachan R; Gupta A; Awasthi PN; Singh P; Anand N; Chandra S; Gaur G; Husain N; Sachan KD
J Am Soc Cytopathol; 2023; 12(5):351-361. PubMed ID: 37244848
[TBL] [Abstract][Full Text] [Related]
16. Suspicious for Malignancy Diagnoses on Pleural Effusion Cytology.
Rodriguez EF; Pastorello RG; Morris P; Saieg M; Chowsilpa S; Maleki Z
Am J Clin Pathol; 2020 Aug; 154(3):394-402. PubMed ID: 32525969
[TBL] [Abstract][Full Text] [Related]
17. [Cytology of body cavity fluids - established methods and new developments].
Engels M
Pathologe; 2022 Mar; 43(2):91-98. PubMed ID: 34994855
[TBL] [Abstract][Full Text] [Related]
18. Number of mesothelial cells as a measure of adequacy criteria for pleural effusions: A multi-institutional study.
Rodriguez EF; Morris PC; Calsavara V; Pastorello RG; Saieg M
Cytopathology; 2020 May; 31(3):223-227. PubMed ID: 32048382
[TBL] [Abstract][Full Text] [Related]
19. A retrospective analysis of serous effusions based on the newly proposed international system for reporting serous fluid cytopathology: a report of 3633 cases in an oncological center.
Zhu YL; Ren WH; Wang Q; Jin HZ; Guo YY; Lin DM
Diagn Pathol; 2022 Jul; 17(1):56. PubMed ID: 35780135
[TBL] [Abstract][Full Text] [Related]
20. Categorisation of serous effusions using the International System for Reporting Serous Fluid Cytopathology and assessment of risk of malignancy with diagnostic accuracy.
Ahuja S; Malviya A
Cytopathology; 2022 Mar; 33(2):176-184. PubMed ID: 34913541
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]